Two posters presented at ASN Kidney Week 2023 analyzed real-world data on Chronic Kidney Disease (CKD) to address knowledge gaps and inform future diagnosis and treatment approaches. The first study, by Pollock et al., used data from the iCaReMe Global Registry that assessed the quality of care for patients with CKD. The study found that one key obstacle in CKD management is the poor screening and underdiagnosis of patients. The cohort study included 2977 adults from 21 countries and found that diabetic kidney disease and hypertensive kidney disease were the most prevalent forms of CKD.
The second study, by Chatterjee et al., analyzed data from 2009 to 2020 to quantify diagnosis delays in CKD patients in the US. The study found an average diagnosis delay of 469 days, and the absence of heart failure or diabetes correlated with longer diagnosis delays. The researchers emphasized the need to reduce these delays to improve CKD management in the future. Both studies highlight the importance of early detection and management of CKD and underline the additional risks when comorbidities accompany CKD.
To read more, click here.
[Source: American Journal of Managed Care, November 3rd, 2023]